Skip to main content

CHD1 Recombinant Enzymes

Novus Biologicals, part of Bio-Techne | Catalog # NBP3-48862

Catalog #
Availability
Size / Price
Qty
Loading...
NBP3-48862

Key Product Details

Source

Sf 9 (baculovirus)

Conjugate

Unconjugated

Product Specifications

Description

Human CHD1 (aa 1-1709) fused to 6xHis and FLAG-tag at the N-terminus. (Uniprot: O14646-2)

Purity

Immunogen affinity purified

Protein / Peptide Type

Recombinant Enzymes

Formulation, Preparation and Storage

NBP3-48862
Formulation 20 mM Tris-HCl, pH 7.9, 150 mM NaCl, 15% glycerol, 2 mM MgCl2, 0.2 mM EDTA, 1 mM DTT, 10 mM beta-glycerophospate, 0.4 mM PMSF, 1 mM benzamidine and 0.4 mg/ml recombinant human insulin
Preservative No Preservative
Concentration Please see the vial label for concentration. If unlisted please contact technical services.
Shipping The product is shipped with dry ice or equivalent. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage Store at -80C. Avoid freeze-thaw cycles.

Background: CHD1

The CHD family of proteins is characterized by the presence of chromo (chromatin organization modifier) domains and SNF2-related helicase/ATPase domains. CHD genes alter gene expression possibly by modification of chromatin structure thus altering access of the transcriptional apparatus to its chromosomal DNA template.

Long Name

Chromodomain Helicase DNA Binding Protein 1

Alternate Names

ATP-dependent helicase CHD1, CHD-1, chromodomain helicase DNA binding protein 1, chromodomain-helicase-DNA-binding protein 1, DKFZp686E2337, EC 3.6.1, EC 3.6.4.12

Gene Symbol

CHD1

Additional CHD1 Products

Product Documents for CHD1 Recombinant Enzymes

Certificate of Analysis

To download a Certificate of Analysis, please enter a lot number in the search box below.

Product Specific Notices for CHD1 Recombinant Enzymes

This product is for research use only and is not approved for use in humans or in clinical diagnosis. This product is guaranteed for 1 year from date of receipt.

Loading...
Loading...
Loading...